About Us
Dorothy Abel
Dorothy Abel, BSBME, retired from the FDA after over 30 years of regulating vascular and endovascular devices. While at the FDA, she was the primary liaison to medical professional societies to develop appropriate clinical evaluations of vascular and endovascular grafts. She was the convener or project leader for the ISO Vascular Prostheses Committee for over 25 years and is an AIMBE Fellow. She co-founded the Early Feasibility Study Program and worked on other Center initiatives to promote innovation. She has been a member of the steering committee for the Greenberg Stent Summit for over 10 years. Dorothy’s focus areas include device evaluation strategy development, clinical evaluation strategic planning, FDA submission planning, drafting or review of FDA submissions, and FDA meeting support.
Ben Wolf
Ben Wolf has over 20 years of industry experience, working across a broad range of functional areas including R&D, manufacturing engineering, program management, product development, and business leadership. Ben has a master’s degree in mechanical engineering. He began his career developing electronic test equipment, before moving into the medical device industry. Ben has worked in startups and large companies, most recently spending 15 years with Medtronic, focused on developing stent-grafts. Ben’s focus areas include fatigue and durability testing, in vivo boundary conditions development, computational modeling, nitinol stent design, bench test methods, failure and root cause analysis, standards development, and due diligence assessments.